Predictors of primary dose reduction (PDR) among patients (pts) age 65 and older receiving adjuvant chemotherapy (chemo).
Heidi D. Klepin(Wake Forest University), Arti Hurria(Unknown), Ajeet Gajra(Pinnacle Clinical Research), Reena Jayani(Vanderbilt University Medical Center), Supriya G. Mohile(University of Rochester Medical Center), Katherine Hansen, Kayo Togawa, William P. Tew(Memorial Sloan Kettering Cancer Center), Stuart M. Lichtman(Memorial Sloan Kettering Cancer Center), S. Klapper, Vani Katheria(City of Hope), CP Gross, Rupal Ramani, Jean Brown, Molly Hardt, Fontayne Wong, Cynthia Owusu
Cited by 2
Related Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737